Medical technology company Stryker has completed the acquisition of US-based medical device company Gauss Surgical for an undisclosed sum.

Based in Menlo Park, California, Gauss Surgical has developed an artificial intelligence (AI) enabled platform called Triton for real-time monitoring of blood loss during surgery.

Triton integrates the power of AI with the simplicity of the iPhone to deliver accurate blood loss during delivery and postpartum care, according to Gauss Surgical.

During cesarean sections, the AI-enabled platform acquires sponge and canister images to precisely monitor blood loss in real time. It has the potential to distinguish between blood and non-sanguinous fluids using advanced algorithms.

According to the company, Triton has shown improvements in maternal and surgical care through earlier recognition of hemorrhage leading to earlier intervention.

Gauss Surgical CEO and founder Siddarth Satish said: “Since the advent of modern surgery, visual estimation of blood loss has remained a notoriously inaccurate and imprecise standard of care.”

The post-partum hemorrhage, a leading cause of maternal death, is said to be experienced by up to 5% of mothers. Studies indicate that 70% of the cases can be prevented, said the company.

Stryker’s instruments division president Dylan Crotty said: “Gauss Surgical’s innovative Triton technology will help fill the void of quantifying blood loss to enable accuracy, early detection of hemorrhage and prevention of maternal morbidity.

“Our belief is that Triton technology will help improve the industry standards for quantifying blood loss in the labor and delivery department, furthering Stryker’s commitment to improve safety and outcomes for our caregivers and their patients.”

In January this year, Stryker acquired US-based privately held company OrthoSensor, a key contributor to the digital evolution of musculoskeletal care and sensor technology for total joint replacement.